Skip to main content
Erschienen in: Archives of Dermatological Research 1/2017

22.11.2016 | Review

Genetic susceptibility to cutaneous radiation injury

verfasst von: Amy Huang, Sharon A. Glick

Erschienen in: Archives of Dermatological Research | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The use of ionizing radiation is critical to cancer treatment and fluoroscopic procedures. However, despite efforts to minimize total radiation dose, many patients experience toxic cutaneous side-effects of ionizing radiation, ranging from mild erythema to subcutaneous fibrosis, telangiectasia formation, and ulceration. Extent of injury is highly variable among patients. Studying the genetic determinants of radiation injury can help develop protocols to reduce radiation toxicity, as well as drive research into effective modulators of the genes and gene products associated with radiation injury. Many studies in the past two decades have identified single-nucleotide polymorphisms that may be associated with susceptibility to cutaneous radiation injury, such as those in genes related to the following cellular responses to ionizing radiation: inflammation, DNA repair, oxidation and stress response, and cell-cycle and apoptosis. This review summarizes the current literature on potential major genes and polymorphisms, in the previously described damage response pathways, that are involved in susceptibility to cutaneous radiation injury. Potential pitfalls of current research and further avenues of discovery will be explored.
Literatur
1.
Zurück zum Zitat Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N (2010) Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res 173:505–511CrossRefPubMed Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N (2010) Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res 173:505–511CrossRefPubMed
2.
Zurück zum Zitat Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D, Haase W et al (2006) Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 8:R40CrossRefPubMedPubMedCentral Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D, Haase W et al (2006) Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res 8:R40CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Andreassen CN (2005) Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 44:801–815CrossRefPubMed Andreassen CN (2005) Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 44:801–815CrossRefPubMed
4.
Zurück zum Zitat Andreassen CN, Alsner J, Overgaard J (2002) Does variability in normal tissue reactions after radiotherapy have a genetic basis–where and how to look for it? Radiother Oncol 64:131–140CrossRefPubMed Andreassen CN, Alsner J, Overgaard J (2002) Does variability in normal tissue reactions after radiotherapy have a genetic basis–where and how to look for it? Radiother Oncol 64:131–140CrossRefPubMed
5.
Zurück zum Zitat Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J et al (2005) TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75:18–21CrossRefPubMed Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J et al (2005) TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75:18–21CrossRefPubMed
6.
Zurück zum Zitat Anscher MS, Crocker IR, Jirtle RL (1990) Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res 122:77–85CrossRefPubMed Anscher MS, Crocker IR, Jirtle RL (1990) Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res 122:77–85CrossRefPubMed
7.
Zurück zum Zitat Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G, Jirtle RL (1998) Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41:1029–1035CrossRefPubMed Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G, Jirtle RL (1998) Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41:1029–1035CrossRefPubMed
8.
Zurück zum Zitat Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J et al (1997) Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76:1546–1549CrossRefPubMedPubMedCentral Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J et al (1997) Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76:1546–1549CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J et al (2012) Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol 105:289–295CrossRefPubMedPubMedCentral Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J et al (2012) Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol 105:289–295CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L et al (2014) A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiother Oncol 111:178–185CrossRefPubMed Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L et al (2014) A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiother Oncol 111:178–185CrossRefPubMed
11.
Zurück zum Zitat Bremer M, Klopper K, Yamini P, Bendix-Waltes R, Dork T, Karstens JH (2003) Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother Oncol 69:155–160CrossRefPubMed Bremer M, Klopper K, Yamini P, Bendix-Waltes R, Dork T, Karstens JH (2003) Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother Oncol 69:155–160CrossRefPubMed
12.
Zurück zum Zitat Caldecott KW (2008) Single-strand break repair and genetic disease. Nat Rev Genet 9:619–631PubMed Caldecott KW (2008) Single-strand break repair and genetic disease. Nat Rev Genet 9:619–631PubMed
13.
Zurück zum Zitat Chen X, Liao C, Chu Q, Zhou G, Lin X, Li X, Lu H et al (2014) Dissecting the molecular mechanism of ionizing radiation-induced tissue damage in the feather follicle. PLoS One 9:e89234CrossRefPubMedPubMedCentral Chen X, Liao C, Chu Q, Zhou G, Lin X, Li X, Lu H et al (2014) Dissecting the molecular mechanism of ionizing radiation-induced tissue damage in the feather follicle. PLoS One 9:e89234CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Clarke RA, Goozee GR, Birrell G, Fang ZM, Hasnain H, Lavin M, Kearsley JH (1998) Absence of ATM truncations in patients with severe acute radiation reactions. Int J Radiat Oncol Biol Phys 41:1021–1027CrossRefPubMed Clarke RA, Goozee GR, Birrell G, Fang ZM, Hasnain H, Lavin M, Kearsley JH (1998) Absence of ATM truncations in patients with severe acute radiation reactions. Int J Radiat Oncol Biol Phys 41:1021–1027CrossRefPubMed
15.
Zurück zum Zitat De Langhe S, Mulliez T, Veldeman L, Remouchamps V, van Greveling A, Gilsoul M, De Schepper E et al (2014) Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy. BMC Cancer 14:711CrossRefPubMedPubMedCentral De Langhe S, Mulliez T, Veldeman L, Remouchamps V, van Greveling A, Gilsoul M, De Schepper E et al (2014) Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy. BMC Cancer 14:711CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Doctrow SR, Lopez A, Schock AM, Duncan NE, Jourdan MM, Olasz EB, Moulder JE et al (2013) A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin. J Invest Dermatol 133:1088–1096CrossRefPubMed Doctrow SR, Lopez A, Schock AM, Duncan NE, Jourdan MM, Olasz EB, Moulder JE et al (2013) A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin. J Invest Dermatol 133:1088–1096CrossRefPubMed
17.
Zurück zum Zitat Dong L, Cui J, Tang F, Cong X, Han F (2015) Ataxia telangiectasia-mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 91:1090–1098CrossRefPubMed Dong L, Cui J, Tang F, Cong X, Han F (2015) Ataxia telangiectasia-mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 91:1090–1098CrossRefPubMed
18.
Zurück zum Zitat Fachal L, Gomez-Caamano A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL et al (2014) A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet 46:891–894CrossRefPubMed Fachal L, Gomez-Caamano A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL et al (2014) A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet 46:891–894CrossRefPubMed
19.
Zurück zum Zitat Frazier TH, Richardson JB, Fabre VC, Callen JP (2007) Fluoroscopy-induced chronic radiation skin injury: a disease perhaps often overlooked. Arch Dermatol 143:637–640CrossRefPubMed Frazier TH, Richardson JB, Fabre VC, Callen JP (2007) Fluoroscopy-induced chronic radiation skin injury: a disease perhaps often overlooked. Arch Dermatol 143:637–640CrossRefPubMed
20.
Zurück zum Zitat Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, Osman A, Plumb M (2007) The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96:1001–1007CrossRefPubMedPubMedCentral Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, Osman A, Plumb M (2007) The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96:1001–1007CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Gonzalez F, Georgieva D, Vanoli F, Shi ZD, Stadtfeld M, Ludwig T, Jasin M et al (2013) Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state. Cell Rep 3:651–660CrossRefPubMedPubMedCentral Gonzalez F, Georgieva D, Vanoli F, Shi ZD, Stadtfeld M, Ludwig T, Jasin M et al (2013) Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state. Cell Rep 3:651–660CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND et al (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93–97CrossRefPubMed Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND et al (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93–97CrossRefPubMed
23.
Zurück zum Zitat Hall EJ, Schiff PB, Hanks GE, Brenner DJ, Russo J, Chen J, Sawant SG et al (1998) A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 4:385–389PubMed Hall EJ, Schiff PB, Hanks GE, Brenner DJ, Russo J, Chen J, Sawant SG et al (1998) A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 4:385–389PubMed
24.
Zurück zum Zitat Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW (2004) Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 44:74–82CrossRefPubMed Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW (2004) Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 44:74–82CrossRefPubMed
25.
Zurück zum Zitat Haston CK, Travis EL (1997) Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 57:5286–5291PubMed Haston CK, Travis EL (1997) Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 57:5286–5291PubMed
26.
Zurück zum Zitat Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22:917–922CrossRefPubMed Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22:917–922CrossRefPubMed
27.
Zurück zum Zitat Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54:28–46CrossRefPubMed Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54:28–46CrossRefPubMed
28.
Zurück zum Zitat Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, Akimoto T, Hareyama M et al (2008) IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res 14:6683–6689CrossRefPubMed Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, Akimoto T, Hareyama M et al (2008) IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res 14:6683–6689CrossRefPubMed
29.
Zurück zum Zitat Koike M, Shiomi T, Koike A (2005) Identification of Skin injury-related genes induced by ionizing radiation in human keratinocytes using cDNA microarray. J Radiat Res 46:173–184CrossRefPubMed Koike M, Shiomi T, Koike A (2005) Identification of Skin injury-related genes induced by ionizing radiation in human keratinocytes using cDNA microarray. J Radiat Res 46:173–184CrossRefPubMed
30.
Zurück zum Zitat Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W et al (2008) Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 122:1333–1339CrossRefPubMed Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W et al (2008) Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 122:1333–1339CrossRefPubMed
31.
Zurück zum Zitat Lee YS, Choi DK, Kim CD, Im M, Mollah ML, Jang JY, Oh TJ et al (2006) Expression profiling of radiation-induced genes in radiodermatitis of hairless mice. Br J Dermatol 154:829–838CrossRefPubMed Lee YS, Choi DK, Kim CD, Im M, Mollah ML, Jang JY, Oh TJ et al (2006) Expression profiling of radiation-induced genes in radiodermatitis of hairless mice. Br J Dermatol 154:829–838CrossRefPubMed
32.
Zurück zum Zitat Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S (1999) TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer 84:155–159CrossRefPubMed Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S (1999) TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer 84:155–159CrossRefPubMed
33.
Zurück zum Zitat Li H, You Y, Lin C, Zheng M, Hong C, Chen J, Li D et al (2013) XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients. Radiat Oncol 8:31CrossRefPubMedPubMedCentral Li H, You Y, Lin C, Zheng M, Hong C, Chen J, Li D et al (2013) XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients. Radiat Oncol 8:31CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Liao C, Xie G, Zhu L, Chen X, Li X, Lu H, Xu B et al (2016) p53 is a direct transcriptional repressor of keratin 17: lessons from a rat model of radiation dermatitis. J Invest Dermatol 136:680–689CrossRefPubMed Liao C, Xie G, Zhu L, Chen X, Li X, Lu H, Xu B et al (2016) p53 is a direct transcriptional repressor of keratin 17: lessons from a rat model of radiation dermatitis. J Invest Dermatol 136:680–689CrossRefPubMed
35.
Zurück zum Zitat Lichtenstein DA, Klapholz L, Vardy DA, Leichter I, Mosseri M, Klaus SN, Gilead LT (1996) Chronic radiodermatitis following cardiac catheterization. Arch Dermatol 132:663–667CrossRefPubMed Lichtenstein DA, Klapholz L, Vardy DA, Leichter I, Mosseri M, Klaus SN, Gilead LT (1996) Chronic radiodermatitis following cardiac catheterization. Arch Dermatol 132:663–667CrossRefPubMed
36.
Zurück zum Zitat Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E et al (2011) Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 81:52–58CrossRefPubMed Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E et al (2011) Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 81:52–58CrossRefPubMed
37.
Zurück zum Zitat Marangoni E, Foray N, O’Driscoll M, Douc-Rasy S, Bernier J, Bourhis J, Jeggo P (2000) A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells. Nucleic Acids Res 28:4778–4782CrossRefPubMedPubMedCentral Marangoni E, Foray N, O’Driscoll M, Douc-Rasy S, Bernier J, Bourhis J, Jeggo P (2000) A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells. Nucleic Acids Res 28:4778–4782CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM et al (2015) Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527:186–191CrossRefPubMedPubMedCentral Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM et al (2015) Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527:186–191CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Quarmby S, Fakhoury H, Levine E, Barber J, Wylie J, Hajeer AH, West C et al (2003) Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79:137–143CrossRefPubMed Quarmby S, Fakhoury H, Levine E, Barber J, Wylie J, Hajeer AH, West C et al (2003) Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79:137–143CrossRefPubMed
40.
Zurück zum Zitat Raabe A, Derda K, Reuther S, Szymczak S, Borgmann K, Hoeller U, Ziegler A et al (2012) Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiat Oncol 7:65CrossRefPubMedPubMedCentral Raabe A, Derda K, Reuther S, Szymczak S, Borgmann K, Hoeller U, Ziegler A et al (2012) Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiat Oncol 7:65CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Ramsay J, Birrell G, Lavin M (1998) Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47:125–128CrossRefPubMed Ramsay J, Birrell G, Lavin M (1998) Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47:125–128CrossRefPubMed
42.
Zurück zum Zitat Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, Giotis A et al (2010) Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol 17:94–112PubMedPubMedCentral Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, Giotis A et al (2010) Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol 17:94–112PubMedPubMedCentral
43.
Zurück zum Zitat Schecter AK, Lewis MD, Robinson-Bostom L, Pan TD (2003) Cardiac catheterization-induced acute radiation dermatitis presenting as a fixed drug eruption. J Drugs Dermatol 2:425–427PubMed Schecter AK, Lewis MD, Robinson-Bostom L, Pan TD (2003) Cardiac catheterization-induced acute radiation dermatitis presenting as a fixed drug eruption. J Drugs Dermatol 2:425–427PubMed
44.
Zurück zum Zitat Schirmer MA, Mergler CP, Rave-Frank M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC et al (2012) Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant. Int J Radiat Oncol Biol Phys 83:149–157CrossRefPubMed Schirmer MA, Mergler CP, Rave-Frank M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC et al (2012) Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant. Int J Radiat Oncol Biol Phys 83:149–157CrossRefPubMed
45.
Zurück zum Zitat Schwarz A, Stander S, Berneburg M, Bohm M, Kulms D, van Steeg H, Grosse-Heitmeyer K et al (2002) Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 4:26–31CrossRefPubMed Schwarz A, Stander S, Berneburg M, Bohm M, Kulms D, van Steeg H, Grosse-Heitmeyer K et al (2002) Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 4:26–31CrossRefPubMed
46.
Zurück zum Zitat Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J et al (2015) XRCC1 polymorphism associated with late toxicity after radiation therapy in breast cancer patients. Int J Radiat Oncol Biol Phys 92:1084–1092CrossRefPubMed Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J et al (2015) XRCC1 polymorphism associated with late toxicity after radiation therapy in breast cancer patients. Int J Radiat Oncol Biol Phys 92:1084–1092CrossRefPubMed
47.
Zurück zum Zitat Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N, Ashton A et al (1998) Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78:922–927CrossRefPubMedPubMedCentral Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N, Ashton A et al (1998) Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78:922–927CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Su M, Yin ZH, Wu W, Li XL, Zhou BS (2014) Meta-analysis of associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and adverse effects of cancer radiotherapy. Asian Pac J Cancer Prev 15:10675–10681CrossRefPubMed Su M, Yin ZH, Wu W, Li XL, Zhou BS (2014) Meta-analysis of associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and adverse effects of cancer radiotherapy. Asian Pac J Cancer Prev 15:10675–10681CrossRefPubMed
49.
Zurück zum Zitat Svensson JP, Stalpers LJ, Esveldt-van Lange RE, Franken NA, Haveman J, Klein B, Turesson I et al (2006) Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 3:e422CrossRefPubMedPubMedCentral Svensson JP, Stalpers LJ, Esveldt-van Lange RE, Franken NA, Haveman J, Klein B, Turesson I et al (2006) Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 3:e422CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W et al (2006) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97:255–262CrossRefPubMed Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W et al (2006) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97:255–262CrossRefPubMed
51.
Zurück zum Zitat Tanteles GA, Murray RJ, Mills J, Barwell J, Chakraborti P, Chan S, Cheung KL et al (2012) Variation in telangiectasia predisposing genes is associated with overall radiation toxicity. Int J Radiat Oncol Biol Phys 84:1031–1036CrossRefPubMed Tanteles GA, Murray RJ, Mills J, Barwell J, Chakraborti P, Chan S, Cheung KL et al (2012) Variation in telangiectasia predisposing genes is associated with overall radiation toxicity. Int J Radiat Oncol Biol Phys 84:1031–1036CrossRefPubMed
52.
Zurück zum Zitat Travis EL (2007) Genetic susceptibility to late normal tissue injury. Semin Radiat Oncol 17:149–155CrossRefPubMed Travis EL (2007) Genetic susceptibility to late normal tissue injury. Semin Radiat Oncol 17:149–155CrossRefPubMed
53.
Zurück zum Zitat Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2:901–908CrossRef Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2:901–908CrossRef
54.
Zurück zum Zitat Weissberg JB, Huang DD, Swift M (1998) Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. Int J Radiat Oncol Biol Phys 42:1133–1136CrossRefPubMed Weissberg JB, Huang DD, Swift M (1998) Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. Int J Radiat Oncol Biol Phys 42:1133–1136CrossRefPubMed
55.
Zurück zum Zitat West C, Rosenstein BS (2010) Establishment of a radiogenomics consortium. Radiother Oncol 94:117–118CrossRefPubMed West C, Rosenstein BS (2010) Establishment of a radiogenomics consortium. Radiother Oncol 94:117–118CrossRefPubMed
Metadaten
Titel
Genetic susceptibility to cutaneous radiation injury
verfasst von
Amy Huang
Sharon A. Glick
Publikationsdatum
22.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 1/2017
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1702-3

Weitere Artikel der Ausgabe 1/2017

Archives of Dermatological Research 1/2017 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.